Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12

Trial Status

Terminated2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT03283631Phase 1Terminated
Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM
Recurrent GlioblastomaRecurrent Gliosarcoma
PrincipalinvestigatorStart date: 2018-05-30
NCT02864368Phase 1Terminated
Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens
GlioblastomaGlioblastoma Multiforme
PrincipalinvestigatorStart date: 2016-12-07

Research Network

Collaboration Network

4 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Daniel Landi, MD

Duke University

Moderately Similar
7 trials

Shared therapeutic areas:

GlioblastomaRecurrent GlioblastomaRecurrent Gliosarcoma

Worked with same sponsors:

Annias Immunotherapeutics, Inc.Duke Cancer Institute+2 more
Collaborated on 1 trial
Similarity Score34%

Jeffrey Raizer, MD

Northwestern University

Related
8 trials

Shared therapeutic areas:

Glioblastoma MultiformeRecurrent Glioblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Jaymes Holland

Alaunos Therapeutics

Related
8 trials

Shared therapeutic areas:

GlioblastomaGlioblastoma Multiforme
Similarity Score15%

Kevin A camphausen, M.D.

National Cancer Institute (NCI)

Related
17 trials

Shared therapeutic areas:

GlioblastomaGlioblastoma Multiforme

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Annick Desjardins, MD, FRCPC

Duke University

Related
9 trials

Shared therapeutic areas:

GlioblastomaGlioblastoma Multiforme
Similarity Score15%

Maryam Fouladi, MD

Nationwide Children's Hospital

Related
10 trials

Shared therapeutic areas:

GlioblastomaGlioblastoma Multiforme
Similarity Score15%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

GlioblastomaGlioblastoma Multiforme
Similarity Score15%

David A. Reardon, MD

Duke Health

Related
8 trials

Shared therapeutic areas:

GlioblastomaGlioblastoma Multiforme

Worked with same sponsors:

National Institutes of Health (NIH)
Similarity Score15%

Alina Markova, MD

Memorial Sloan Kettering Cancer Center

Related
9 trials

Shared therapeutic areas:

GlioblastomaRecurrent Glioblastoma
Similarity Score15%

Sean Grimm, MD

Northwestern University

Related
2 trials

Shared therapeutic areas:

Glioblastoma Multiforme
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03283631Phase 1PrincipalInvestigator

Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM

Recurrent GlioblastomaRecurrent Gliosarcoma
Terminated
NCT02864368Phase 1PrincipalInvestigator

Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens

GlioblastomaGlioblastoma Multiforme
Terminated

All 2 trials loaded